Literature DB >> 1683319

Flutamide in the treatment of hirsutism.

T Motta1, G Maggi, M Perra, E Azzolari, S Casazza, A D'Alberton.   

Abstract

Ten hirsute women were treated with flutamide (250 mg/day) for 6 months to evaluate its effect. Hair growth as assessed by the Ferriman and Gallwey hair score was significantly reduced in all patients (P less than 0.01). The only significant change in endocrine levels was an increase in serum androstenedione (P less than 0.01). Acne and seborrhea improved markedly. No side effects were noted during the treatment. Our data suggest that the antiandrogenic properties of flutamide render it a suitable single agent in the treatment of hirsutism.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1683319     DOI: 10.1016/0020-7292(91)90772-w

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  2 in total

1.  Flutamide and hirsutism.

Authors:  T Motta; G Maggi; A D'Alberton
Journal:  J Endocrinol Invest       Date:  1994-09       Impact factor: 4.256

Review 2.  A risk-benefit assessment of pharmacological therapies for hirsutism.

Authors:  E Carmina
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.